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Abstract: Six new cyclodiprenyl phenols were synthesized by direct coupling of perillyl alcohol
and the appropriate phenol. Their structures were established by IR, HRMS and mainly NMR.
Three human cancer cell lines—breast (MCF-7), prostate (PC-3) and colon (HT-29)—were used in
antiproliferative assays, with daunorubicin and dunnione as positive controls. Results described in
the article suggest that dihydroxylated compounds 2–4 and monohydroxylated compound 5 display
selectivity against cancer cell lines, cytotoxicity, apoptosis induction, and mitochondrial membrane
impairment capacity. Compound 2 was identified as the most effective of the series by displaying
against all cancer cell lines a cytotoxicity close to dunnione antineoplastic agent, suggesting that the
cyclodiprenyl phenols from perillyl alcohol deserve more extensive investigation of their potential
medicinal applications.
Keywords: perillyl alcohol; synthesis; cyclodiprenyl phenols; antiproliferative agents
1. Introduction
Many natural products of mixed biosynthesis, such as meroterpenes, have been reported from both
terrestrial and marine sources [1]. In this context, recent years have seen major advances in research
and development concerning meroterpenes whose antiproliferative activity appears promising for
the treatment of cancer [2–4]. These are mostly hydroquinones with a terpenoid portion ranging
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in size from one to nine isoprene units. In particular, sesquiterpene hydroquinones from sponges
such as arenarol, fulvanin-2, yahazunol, avinosol and avarol offer promising opportunities for the
development of new antitumor agents [2]. Based on these premises, the potential of meroterpenes
is of great interest; however, low yields of these compounds have traditionally been obtained from
natural sources [5–8]. For these reasons, research efforts to chemically synthesize these compounds,
their structural analogs, and their derivatives have intensified in recent decades [9–12]. However,
little has been done on the synthesis and biological evaluation of hybrid molecules combining cyclic
monoterpenes and synthetic phenols [13–15]. One of the best known cyclic monoterpenes is perillyl
alcohol, a small lipophilic allylic alcohol found predominantly in essential oils from Perilla frutescens,
cherries, cranberries, lavender, celery seed and spearmint [16,17], which exhibit chemopreventive and
cytotoxic activity against a wide variety of cancer cell lines [18–24]. Additionally, the present findings
suggest that perillyl alcohol may be used as a prototype for the prevention of ethanolic liver injury and
in therapy of patients with malignant brain tumors [25,26]. These facts motivated us to accomplish the
synthesis of novel cyclodiprenyl phenols from perillyl alcohol 1 and different phenol moieties. In terms
of application, our final aim was the evaluation of their biological activity as potential antiproliferative
agents against a panel of cancer cell lines.
2. Results and Discussion
2.1. Synthesis of Cyclodiprenyl Phenols
The new cyclodiprenyl phenols 2–7 were synthesized from perillyl alcohol 1 by alkylation with
the corresponding phenol in acetonitrile in the presence of boron trifluoride diethyl etherate as catalyst
(Scheme 1) [27].
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Afterwards, novel cyclodiprenyl phenols were obtained in moderate yields. Nevertheless,
compound 1 reacts with resorcinol in the presence of boron trifluoride etherate to produce compound
3 as a major product via Friedel–Crafts alkylation, and compound 4 as a minor product via
retro-Friedel–Crafts alkylation, due to this Lewis acid mediated coupling is reversible (Scheme 1) [28].
Since no other minor products resulted from reaction of perillyl alcohol 1 with other phenols under
the same conditions, such byproducts could thus be recycled to contribute towards the yield of the
desired product.
The structure of each new derivatives 2–7 was unambiguously assigned by IR spectroscopy,
1H-/13C-NMR data, and confirmed by high resolution mass spectrometry. The 1H- and 13C-NMR data
for the derivatives of perillyl alcohol were nearly identical in the aliphatic region of the spectra [29,30],
and the substitution position of perilic unit in aromatic ring was established by two-dimensional (2D)
HMBC correlations (see Supplementary Materials).
For the synthesis of compound 2, pyrocatechol and perillyl alcohol were used. In the 1H-NMR
spectrum, the signals at δH = 6.76 (d, J = 8.0 Hz, 1H, H-6), 6.68 (s, 1H, H-3) and 6.60 (d, J = 8.0 Hz,
1H, H-5) ppm confirm the presence of a trisubstituted aromatic system. In the 2D HMBC spectrum,
the signal at δH = 3.27 ppm (s, 2H, H-7′) showed 3JH-C coupling with C-5 and C-3 (δC = 121.2 and
115.1 ppm, respectively) and 2JH-C coupling with C-4 (δC = 137.1 ppm), confirming that perilic unit
was substituted in the meta position respect to the hydroxyl group on the aromatic core, while other
HMBC correlations are shown in Figure 1.Molecules 2018, 23, x FOR PEER REVIEW  4 of 13 
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On the other hand, the direct alkylation between resorcinol and 1 produced compound 3.
The structure and pattern of the aromatic monosubstitution of this compound were established
from NMR data spectra. In 1H-NMR spectrum, the signals at δH = 6.90 ppm (d, J = 8.4 Hz, 1H, H-5)
and δH = 6.34 ppm (m, 2H, H-2 and H-6) confirm the presence of a trisubstituted aromatic system.
The ortho position of the perillic unit substitution in the aromatic core was determined from the 2D
HMBC spectrum, the signal at δH = 3.27 ppm (s, 2H, H-7′) showed heteronuclear 3JH-C coupling with
C-3 (δC = 156.0 ppm) and C-5 (δC = 131.2 ppm) and 2JH–C coupling C-4 (δC = 117.0 ppm).
For compound 4, the signal at δH = 4.36 ppm (s, 2H, H-7′) ascribed to O-CH2 protons of an alkoxy
chain linked to the aromatic system is observed. This is characteristic of allylic chains on aromatic rings,
resulting from the alkylation reaction. These data also were corroborated by 2D HMBC correlations,
where H-7′ showed heteronuclear 3J correlations with C-3 (δC = 160.4 ppm), C-2′ (δC = 125.1 ppm) and
heteronuclear 2J correlations were also observed with C-1′ (δC = 133.4 ppm) (Figure 1).
Our next goal was the preparation of compound 5, using 1 and hydroquinone as the starting
materials. In the 1H-NMR spectrum, the three aromatic signals at δH = 6.70 (d, J = 8.3 Hz, 1H,
H-6), 6.60 (d, J = 8.3 Hz, 1H, H-5) and δH = 6.58 (s, H, H-3) ppm show a typical ABC pattern
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(1,2,4. tri-substituted aromatic system), the spectrum in this region being identical with that of
prenylhydroquinone and geranylhydroquinone [31]. The HMBC correlations are shown in Figure 1.
The following step consisted in the preparation of compound 6. The structure of 6 was established
by NMR, where aromatic signals at δH = 6.49 (d, J = 8.3 Hz, 1H) and 6.43 (d, J=8.3 Hz, 1H) were
observed as two doublets for hydrogens H-5 and H-6 respectively, confirming the aromatic substitution.
Additionally, in the HMBC spectrum, the signal at δH = 3.25 ppm assigned to H-7′ (s, 2H) shows 3JH-C
coupling with C-3 (δC = 143.0 ppm), C-5 (δC = 121.2 ppm) and C-6 (δC = 122.6 ppm) and 2JH-C coupling
with C-1′ and C-4 (δC = 137.4 ppm and 117.6 ppm respectively). These HMBC correlations are shown
in Figure 2.
Finally, the synthesis of compound 7 was developed by a direct alkylation reaction between
phloroglucinol and 1. The determination of structure of 7 was mainly established by the NMR aromatic
signal at δH = 5.98 ppm, where a singlet for two hydrogens (H-4 and H-6) was observed, confirming
the unique possibility of aromatic monosubstitution. Additionally, the signal at δH = 3.29 ppm to
assigned at H-7′ (d, J = 7.0 Hz, 2H) shows 3JH-C coupling with C-1 and C-3 (δC = 156.3 ppm) and 2JH-C
coupling with C-2 (δC = 103.7 ppm), these HMBC correlations are shown in Figure 2.
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2.2. In Vitro Activities
The natural compound 1 and meroterpenes 2–7 were evaluated for their in vitro cytotoxic activity
on a panel of three human cancer cell lines—MCF-7 (breast), PC-3 (prostate) and HT-29 (colon)—and
two human non-tumoral cell lines, human dermal fibroblasts (HDF) and colon epithelial cells (CoN)
using the conventional sulforhodamine dye assay. The results obtained from these assays are shown
in Table 1.
Table 1. In vitro cytotoxic activity of natural compound 1 and derivatives 2–7.
Compound
IC50 (µM)
MCF-7 PC-3 HT-29 CoN HDF
1 >100 >100 >100 >100 >100
2 25.9 ± 0.1 12.2 ± 0.7 45.1 ± 0.2 >100 >100
3 53.7 ± 0.4 54.5 ± 0.5 >100 >100 >100
4 44.3 ± 0.7 79.0 ± 0.2 >100 >100 >100
5 37.0 ± 0.1 20.5 ± 0.4 >100 >100 >100
6 >100 >100 >100 >100 >100
7 >100 >100 >100 >100 >100
Dunnione 14.56 ± 0.04 26.51 ± 0.05 30.32 ± 0.05 24.07 ± 0.55 27.03 ± 0.65
Daunorubicin 0.21 ± 0.01 0.39 ± 0.06 14.7 ± 0.9 - 14.09 ± 0.45
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In this study, we evaluated the anti-cancer activity of a new cyclodiprenyl phenols against
human prostate cancer cells (PC-3), reast B (MCF-7) and colon (HT-29) cancer cells. Cell viability
analysis of cyclodiprenyl phenols indicated that compound derivatives showed more pronounced
anti-proliferative activity than 1. According to the IC50 values summarized in Table 1, it is evident
that the alkylation of phenols by perillyl alcohol, as in derivatives 2, 3, 4 and 5 induces a remarkable
increase of the cytotoxic activity in all the evaluated cell lines, compared to compound 1. However,
compounds 2 and 5 inhibit cellular viability on prostate cancer cells when compared with dunnione.
Nevertheless, the compounds 6 and 7 did not affect the viability of the cells lines studied. Among the
members of this series, compound 2 showed the highest cytotoxic activity against all cancer cell lines,
without affecting non-tumoral cells. This great cytotoxicity can be influenced by the position of the
perillic fragment with respect to the catechol system [32–34]. Phenolic compounds are the subject of
intense scientific research because of the way they work to prevent or lower the risk of various cancers.
Cancers caused or induced by free radicals can be effectively scavenged by polyphenols. We conclude
on the basis of bond dissociation enthalpies (BDE) that the relative activity position of OH in the
benzene ring is very important. According to literature, two postulates are proposed [35]:
(i) The position of OH′s is very determinant for lower BDE, but not the number of OH′s.
(ii) Increasing the number of OH′s in the vicinal (ortho) position, that is, more intramolecular
hydrogen bond, decreases the BDE, but increasing the number of OH′s in the meta position
has little impact on BDEs compared with a single OH group.
The empirical evidence shows that when the chain is in the meta position with respect to the OH
group (compound 5) the molecules obtained have a greater cytotoxic activity and the activity increases
when the molecule presents an OH in the vicinal ortho position (compound 2) in comparison with the
molecules (compound 3, 4, 6, and 7) that presented the chain in the position ortho to the OH group.
Since compounds 2–5 had strong inhibitory effects on various cancer cell line growth and certain
selectivity in relation to non-tumoral cells, we decided to study the effect of these compounds.
To elucidate whether compounds 2–5 reduced the cell viability of MCF-7, PC-3 and HDF cells
by inducing apoptosis as was previously described for perillyl alcohol [21], the cells treated with
compounds 2–5 for 48 h were stained with Hoestch 33342 for 30 min. Condensed and/or fragmented
nuclei, as an apoptotic characteristic, were observed under a fluorescence microscope (200×) and
quantified in MCF-7, PC-3 and HDF cells, as shown in Table 2. Exposure to compounds 2–4 significantly
affected the condensation and/or fragmentation nuclei in the treated cells versus control cells. The data
indicates that compounds 2–4 induce changes in the morphology of the nuclei, which are related
to an apoptotic cell death cycle [36]. On other hand, treatment with compound 5 had no effect in
the morphology of the nuclei, suggesting that the cytotoxicity induced by this compound is not
associated to an apoptotic cell death pathway. The analyzed compounds have no effect in nuclear
morphology of HDF cells correlating with cytotoxicity data (Table 1) and suggesting a selective effect
of compounds 2–4.
Table 2. Percentage of condensed and/or fragmented nuclei after treatment with compounds 2–5.
Compound MCF-7 PC-3 HDF
2 29.4 ± 4.3 ** 31.4 ± 3.3 ** 8.7 ± 1.4
3 16.8 ± 3.1 * 14.5 ± 3.1 * 6.8 ± 1.6
4 17.2 ± 2.9 * 13.8 ± 2.1 * 5.6 ± 1.1
5 7.3 ± 1.4 6.0 ± 0.3 7.9 ± 1.2
Control 6.7 ± 1.5 8.6 ± 1.0 6.0 ± 1.1
Values are mean ± S.D. (n = 3); * p < 0.05; ** p < 0.01, significantly different from the control-treated cells.
Mitochondria are important organelles of the apoptosis execution machinery, which includes
pro-apoptotic events involving decreased mitochondrial membrane potential (∆ψm), release of
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cytochrome C and activation of caspase cascade [37,38]. Mitochondria play an important role in the
cell death fate by serving as a convergent center of apoptotic signals originated from both the extrinsic
and intrinsic pathways [39]. The changes induced in the mitochondria membrane potential have
been previously reported to represent a determinant in the execution of cell death [40]. We analyzed
the possible changes induced by the studied compounds in the mitochondrial membrane potential,
using rhodamine 123 to track down changes in mitochondrial function, since fluorescence of the
dye decreases as mitochondrial membrane potential is lost [41]. As shown in Table 3, treatment
with compounds 2–4 (25 µM) significantly increased the percentage of cells without rhodamine
123 (* p < 0.05) in MCF-7 and PC-3 cell lines. Thus, compounds 2–4 induced loss of mitochondrial
membrane potential correlated well with cytotoxic activity and apoptotic nuclear morphology (see
Tables 1 and 2).
Table 3. Percentage of cells without rhodamine-123 after treatment with compounds 2–4 on MCF-7
and PC-3-treated cells.
Compound MCF-7 PC-3
2 69.4 ± 4.3 ** 41.4 ± 4.8 *
3 28.9 ± 2.4 * 29.5 ± 3.7 *
4 34.2 ± 4.9 * 26.5 ± 3.8 *
Control 23.0 ± 2.1 15.6 ± 4.0
Values are mean ± S.D. (n = 3); * p < 0.05; ** p < 0.01, significantly different from the control-treated cells.
In addition, a representative histogram showing changes of mitochondrial membrane permeability
in MCF-7 cells is presented in Figure 3.
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As shown in Figure 3, we observed that MCF-7 cancer cell when treated ith co pound 2 sho ed a
strong loss of mitochondrial permeability effect. This decrease was significative in both the cell lines.
Finally, the decrease of mitochondrial membrane potential is associated to the release of apoptogenic
factors, such as cytochrome c and activation of caspases [42]. Next we investigated the effects of
compounds 2–4 on caspase activity. As shown in Table 4, the caspase activation is higher in cells
exposed to compounds 2–4 than in control cells in both cell lines. That is, compounds 2–4 increase
caspases activity in cancer cells corroborating the cytotoxicity data and indicating that these compounds
induced apoptotic cell death in the cell lines studied.
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Table 4. Percentage of cells with caspases active on MCF-7 and PC-3-treated cells.
Compound MCF-7 PC-3
2 32.4 ± 4.0 ** 23.4 ± 3.0 *
3 15.1 ± 3.2 * 16.5 ± 2.3 *
4 21.4 ± 2.9 * 19.1 ± 2.8 *
Control 9.1 ± 2.1 8.9 ± 2.1
Values are mean ± S.D. (n = 3); * p < 0.05; ** p < 0.01, significantly different from the control-treated cells.
Additionally, a representative histogram showing changes on caspases activity in PC-3-treated
cells is illustrated in Figure 4.
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while 3 has a moderate effect.
On the ot er hand, the results obtained confirm the potent cytotoxic activity of pyrocatechol and
hydroquinone over resorcinol-derived systems against cancer cells is mediated by reactive oxygen
species production via one-el ctron-based redox cycling [44,45]. However, upon administration in
model in vivo, th se comp unds undergo two main metabolic pathways, oxi ation and conjugation.
Oxidation generally leads to electrophilic quinone metabolites able to covalently bind proteins or
DNA. In co trast, t conjugation reactions, sulfation, thylation, and glucuronidation, catalyzed
by the respective enzymes, are effective detoxication echanisms and all w the excretion of the
conjugates into bile and urine [46,47]. Therefore, it is important to determine in future studies the
factors, especially the structural features, which guide to this type of hydroxylated compounds toward
different metabolic pathways and govern their biotransformation. In conclusion, the new cyclodiprenyl
phenols were found to be highly promising potent antiproliferative agents and the presented data
support their candidacy for further studies as a novel class of potential anticancer agents.
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3. Materials and Methods
3.1. General Information
(S)-Perillyl alcohol, pyrocatechol, resorcinol, hydroquinone, pyrogallol, phloroglucinol and the
others chemicals used were of reagent grade and were obtained from Aldrich (St. Louis, MO, USA).
The reaction progress was monitored by thin layer chromatography on silica gel 60 F-254 (Merck,
Darmstadt, Germany), and components were visualized by a VL-4LC UV lamp (Vilber Lournat,
Collégien, France). Purification by flash chromatography was performed on silica gel 60 (particle size
0.032–0.063 mm) also from Merck and recrystallization. Melting points were measured on a SMP3
apparatus (Stuart-Scientific, Staffordshire, UK). FT-IR spectra were recorded on Buck Scientific M500
instrument (Buck Scientific Instrument, East Norwalk, CT, USA). NMR spectra were recorded at room
temperature in solution on a 400 MHz Avance instrument (Bruker, Rheinstetten, Germany). HRMS
spectra were recorded on a MAT 95 XL mass spectrometer (Thermo Finnigan, Bremen, Germany).
3.2. General Procedure for Obtaining Derivatives
In a round bottom flask BF3·OEt2 (0.3 mL, 2.43 mmol) was gradually added at room temperature
to a solution of perillyl alcohol (1, 2.08 mmol) and different phenols (2.29 mmol) in dry acetonitrile
(10 mL). The mixture was stirred at room temperature under a nitrogen atmosphere for 48 h, when
the completion of the reaction was verified by TLC. The mixture was poured onto crushed ice (5 g).
The two phases were separated and the water phase was extracted with diethyl ether (3 × 30 mL).
The combined organic phases were washed with 5% NaHCO3 (15 mL), dried and the solvent was
evaporated. The crude product was subjected to column chromatography (silica gel, n-hexane/ethyl
acetate mixtures of increasing polarity) which provided the target compounds 2–7. The % purity
of compounds 2–7 were confirmed by analytical HPLC (compound 2—98%, compound 3—94%,
compound 4—95%, compound 5—98%, compound 6—96%, and compound 7—97%).
4-{[(4S)-4-Isopropenylcyclohex-1-en-1-yl]methyl}benzene-1,2-diol (2). Pale yellow viscous oil. Yield: 21.9%.
IR υmax (KBr) cm−1: 3350 (O-H), 2920 (C-H), 1643 (C=C), 1515 (C=C), 1435 (C=C), 1276 (C-H). 1H-NMR
(400.1 MHz, CDCl3): 6.76 (d, J = 8.0 Hz, 1H, H-6); 6.68 (s, 1H, H-3); 6.60 (d, J = 8.0 Hz, 1H, H-5); 5.69 (b.s.,
1H, OH); 5.45 (s, 1H, H-2′); 4.69 (s, 2H, H-9′); 3.76 (b.s., 1H, OH); 3.14 (s, 2H, H-7′); 2.14 (m, 2H, H-3β′
and H-4′); 2.02 (m, 3H, H-3α′ and H-6′); 1.85 (m, 1H, H-5β′); 1.74 (s, 3H, H-10′); 1.47 (m, 1H, H-5α′).
13C-NMR (100.6 MHz, CDCl3): 150.1 (C-8′); 143.3 (C-1); 141.6 (C-2); 137.1 (C-1′); 133.4 (C-4); 122.2 (C-2′);
121.2 (C-5); 115.7 (C-6); 115.1 (C-3); 108.4 (C-9′); 43.5 (C-7′); 41.1 (C-4′); 30.5 (C-3′); 28.4 (C-5′); 27.8 (C-6′);
20.7 (C-10′). HRMS: M + H ion m/z 245.1543 (calcd. for C16H21O2, 245.1542).
4-{[(4S)-4-Isopropenylcyclohex-1-en-1-yl]methyl}benzene-1,3-diol (3). Orange solid. Yield: 25.9%. m.p.
77-78 ◦C. IR υmax (KBr) cm−1: 3296 (O-H), 2921 (C-H), 1606 (C=C), 1517 (C=C), 1456 (C=C), 1163 (C-H).
1H-NMR (400.1 MHz, CDCl3): 6.90 (d, J = 8.4 Hz, 1H, H-5); 6.34 (m, 2H, H-2 and H-6); 5.41 (s, 1H,
OH); 4.71 (m, 3H, OH and H-9′); 3.27 (s, 2H, H-7′); 2.16 (m, 2H, H-3β′ and H-4′); 1.98 (m, 3H, H-3α′
and H-6′); 1.78 (m, 1H, H-5β′); 1.73 (s, 3H, H-10′); 1.47 (m, 1H, H-5α′). 13C-NMR (100.6 MHz, CDCl3):
156.0 (C-3); 155.5 (C-1); 149.6 (C-8′); 136.9 (C-1′); 131.5 (C-5); 123.2 (C-2′); 117.0 (C-4); 108.7 (C-9′);
107.5 (C-6); 103.3 (C-2); 40.9 (C-4′); 39.3 (C-7′); 30.6 (C-3′); 28.3 (C-5′); 27.5 (C-6′); 20.7 (C-10′). HRMS:
M + H ion m/z 245.1546 (calcd. for C16H21O2, 245.1542).
3-{[(4S)-4-Isopropenylcyclohex-1-en-1-yl]methoxy}phenol (4). Pale orange viscous oil. Yield: 5.2%. IR υmax
(KBr) cm−1: 3384 (O-H), 2925 (C-H), 1648(C=C), 1458 (C=C), 1382 (C-H), 1199 (Ar-O-R). 1H-NMR
(400.1 MHz, CDCl3): 7.11 (t, J = 8.0 Hz, 1H, H-5); 6.50 (d, J = 7.6 Hz, 1H, H-4); 6.42 (m, 2H, H-2 and H-6);
5.80 (b.s, 1H, OH); 4.73 (m, 3H, OH and H-9′); 4.36 (s, 2H, H-7′); 2.18 (m, 2H, H-3β′ and H-4′); 1.99 (m,
3H, H-3α′ and H-6′); 1.87 (m, 1H, H-5β′); 1.75 (m, 4H, H-10′ and H-5α′). 13C-NMR (100.6 MHz, CDCl3):
160.7 (C-3); 156.3 (C-1); 149.7 (C-8′); 133.4 (C-1′); 130.0 (C-5); 125.1 (C-2′); 108.7 (C-9′); 107.6 (C-4);
107.3 (C-6); 102.3 (C-2); 72.3 (C-7′); 40.9 (C-4′); 30.5 (C-3′); 27.3 (C-5′); 26.3 (C-6′); 20.7 (C-10′). HRMS:
M + H ion m/z 245.1544 (calcd. for C16H21O2, 245.1542).
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2-{[(4S)-4-Isopropenylcyclohex-1-en-1-yl]methyl}benzene-1,4-diol (5). Pale yellow viscous oil. Yield: 28.4%.
IR υmax (KBr) cm−1: 3364 (O-H), 2922 (C-H), 1643 (C=C), 1503 (C=C), 1453 (C=C), 1199 (C-H). 1H-NMR
(400.1 MHz, CDCl3): 6.70 (d, J = 8.3 Hz, 1H, H-6); 6.60 (d, J = 8.3 Hz, 1H, H-5); 6.58 (s, H, H-3);
5.63 (b.s, 1H, H-2); 4.99 (s, 1H, OH); 4.71 (s, 1H, H-9β′); 4.69 (s, 1H, H-9α′); 4.65 (s, 1H, OH); 3.26 (s,
2H, H-7′); 2.16 (m, 2H, H-3β′ and H-4′); 1.98 (m, 3H, H-3α′ and H-6′); 1.80 (m, 1H, H-5β′); 1.72 (s,
3H, H-10′); 1.47 (m, 1H, H-5α′). 13C-NMR (100.6 MHz, CDCl3): 149.6 (C-4); 149.3 (C-1 and C-8′);
136.2 (C-1′); 126.2 (C-2); 123.3 (C-2′); 117.5 (C-6); 114.2 (C-3); 114.0 (C-5); 108.7 (C-9′); 40.9 (C-4′);
39.7 (C-7′); 30.7 (C-3′); 28.5 (C-5′); 27.6 (C-6′); 20.7 (C-10′). HRMS: M + H ion m/z 245.1540 (calcd.
for C16H21O2, 245.1542).
4-{[(4S)-4-Isopropenylcyclohex-1-en-1-yl]methyl}benzene-1,2,3-triol (6). Yellow viscous oil. Yield: 37.8%.
IR υmax (KBr) cm−1: 3375 (O-H), 2921 (C-H), 1627 (C=C), 1458 (C=C), 1367 (C-H), 1221 (C-H). 1H-NMR
(400.1 MHz, CDCl3): 6.49 (d, J = 8.3 Hz, 1H, H-5); 6.43 (d, J = 8.3 Hz, 1H, H-6); 5.60 (s, 1H, H-2); 4.76 (s,
1H, H-9β′); 4.75 (s, 1H, H-9α′); 3.25 (s, 2H, H-7′); 2.11 (m, 2H, H-3β′ and H-4′); 1.98 (m, 3H, H-3α′
and H-6′); 1.89 (m, 1H, H-5β′); 1.71(s, 3H, H-10′); 1.51 (m, 1H, H-5α′). 13C-NMR (100.6 MHz, CDCl3):
150.0 (C-8′); 143.0 (C-3); 142.7 (C-1); 137.4 (C-1′); 131.9 (C-2); 122.6 (C-2′); 121.4 (C-5); 117.6 (C-4);
108.2 (C-9′); 107.4 (C-6); 44.9 (C-4′); 38.9 (C-7′); 29.7 (C-3′); 28.9 (C-5′); 27.3 (C-6′); 21.0 (C-10′). HRMS:
M + H ion m/z 261.1490 (calcd. for C16H21O3, 261.1491).
2-{[(4S)-4-Isopropenylcyclohex-1-en-1-yl]methyl}benzene-1,3,5-triol (7). Brown solid. Yield: 42.6%. m.p.
144–146 ◦C. IR υmax (KBr) cm−1: 3442 (O-H), 2923(C-H), 1632 (C=C), 1463 (C=C), 1223 (C-H). 1H-NMR
(400.1 MHz, CDCl3): 6.02 (b.s, 2H, OH); 5.98 (s, 2H, H-4 and H-6); 5.60 (s, 1H, H-2′); 4.67 (s, 1H, H-9β′);
4.66 (s, 1H, H-9α′); 3.29 (d, J = 7.0 Hz, 2H, H-7′); 2.14 (m, 2H, H-3β′ and H-4′); 1.95 (m, 3H, H-3α′
and H-6′); 1.74 (m, 1H, H-5β′); 1.68 (s, 3H, H-10′); 1.46 (m, 1H, H-5α′). 13C-NMR (100.6 MHz, CDCl3):
156.3 (C-1 and C-3); 155.8 (C-5); 149.7 (C-8′); 137.0 (C-1′); 122.0 (C-2′); 108.5 (C-9′); 103.7 (C-2); 95.7 (C-4
and C-6); 40.9 (C-4′); 30.6 (C-3′ and C-7′); 28.3 (C-5′); 27.5 (C-6′); 20.7 (C-10′). HRMS: M + H ion m/z
261.1496 (calcd. for C16H21O3, 261.1491).
3.3. Cell Lines
The cell lines used in this work were obtained from the American Type Culture Collection
(Rockville, MD, USA). They included human prostate cancer cells (PC-3), breast carcinoma cells
(MCF-7), human colorectal adenocarcinoma cells (HT-29), human dermal fibroblast cells (HDF)
and human colonic epithelial cells (CoN). Cells were grown by the procedure previously described
in reference [48].
3.4. In Vitro Assays for Cellular Viability
The sulforhodamine B assay was assessed by the procedure previously described in reference [49].
Daunorubicin and dunnione were used as positive controls.
3.5. Hoechst 33342 Assay
Morphological changes in the nuclear chromatin of cells undergoing apoptosis were revealed
by a nuclear fluorescent dye, Hoescht 33342 (Sigma-Aldrich, Santiago, Chile) [40]. Briefly, on 24-well
chamber slides, 1 × 104 cells/mL MCF-7, PC-3 and HDF were cultured and exposed to 25 µM
compounds for 48 h. The control group was also exposed to ethanol 1%. After treatments the cells were
washed twice with phosphate buffer solution, fixed with 3.7% formaldehyde and washed again with
phosphate buffer solution. Following the addition of 1 µM Hoechst 33342, the cells were incubated in
a dark room at room temperature for 30 min. After being washed, the cells were examined under an
immunofluorescence microscope (Olympus IX 81 model inverted microscope, Olympus, Tokyo, Japan).
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3.6. Analysis of Mitochondrial Membrane Permeability
Rhodamine 123, a cationic voltage-sensitive probe that accumulates in mitochondria was used to
track down changes in mitochondrial membrane permeability [40]. Exponentially growing cells were
incubated with compounds as indicated previously. Cells were labeled with rhodamine 123 (1 µM final
concentration) at 37 ◦C in culture medium for 60 min before terminating the experiment. Cells were
washed with ice cold phosphate-buffered saline (PBS) and were detached from the plate, the samples
were analyzed by flow cytometry. Data is expressed in percentage of cells without rhodamine 123.
3.7. Caspases Activity Assay
The activity of caspases was determined by using the CaspACE™ FITC-VAD-FMK (Promega,
Santiago, Chile). Briefly, cells were treated with the analysed compounds (0 and 25 µM) for 48 h.
The cells were incubated with CaspACE™ FITC-VAD-FMK in darkness for 20 min at room temperature.
Then, the medium was removed and cells were washed twice with PBS. Exposed cells were collected
by tripsinization and centrifugation (10 min at 1500× g). The supernatant was discarded and the cells
were re-suspended in PBS and analyzed by flow cytometry using the filter FL3. Results are expressed
as percentage of cells stained with CaspACE™ FITC-VAD-FMK [50].
3.8. Statistics
Determinations of in vitro assays were performed in triplicate and the results expressed as mean
values± SD. Statistical significance was defined as p < 0.05. To analyze the normality in the distribution
of the data, the test “Shapiro-Wilk” was used. While for the statistical analysis of data with no normal
distribution, the non-parametric test of “Wilcoxon” with designed range was used.
4. Conclusions
Starting from perillyl alcohol and synthetic phenols, new cyclodiprenyl phenols 2–7 were
synthesized and were tested as potential antiproliferative agents against different cancer cell lines.
Among all the compounds tested, compound 2 showed a strong antiproliferative activity against breast
and prostate cancer cell cultures, while 3 and 4 presented a moderate effect. The results suggest that
new dihydroxylated products present better properties than perillyl alcohol. Additional studies are
needed to confirm the therapeutical potential of the new cyclodiprenyl phenols as well as to assess
their mechanisms of action.
Supplementary Materials: The following are available online. Figure S1: Nuclear magnetic resonance spectra:
compounds 2–7, Figure S2: High-resolution mass spectra: compounds 2–7, Figure S3: Infrared spectra:
compounds 2–7.
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